Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives

Mostrar otras versiones (1)

The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition as...

Descripción completa

Detalles Bibliográficos
Autores principales: Suria, Carles, Bosca-Watts, Marta M., Navarro, Pablo, Tosca, Joan, Anton, Rosario, Sanahuja, Ana, Revaliente, Marta, Minguez, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219948/
https://www.ncbi.nlm.nih.gov/pubmed/34171421
http://dx.doi.org/10.1016/j.gastrohep.2021.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219948/
https://www.ncbi.nlm.nih.gov/pubmed/34171421
http://dx.doi.org/10.1016/j.gastrohep.2021.06.005

Ejemplares similares